Trials / Recruiting
RecruitingNCT07301333
A Study of Single and Multiple Doses of HRS-6257 in Healthy Subjects
A Phase 1 Study To Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and the Effect of Food on the Bioavailability of HRS-6257 in Healthy Subjects
- Status
- Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- Sponsor
- Shanghai Hengrui Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This is a phase I, randomised, single-blind placebo-controlled, 2-part study to assess the safety, tolerability, pharmacokinetics, pharmacodynamics and food effect of single and multiple oral doses of HRS-6257 in healthy volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HRS-6257 | HRS-6257 |
| DRUG | placebo | placebo |
Timeline
- Start date
- 2025-12-30
- Primary completion
- 2026-05-01
- Completion
- 2026-05-01
- First posted
- 2025-12-24
- Last updated
- 2026-04-07
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07301333. Inclusion in this directory is not an endorsement.